Shimadzu’s Nexera UC Wins R&D 100 Award
PTSM: Pharmaceutical Technology Sourcing and Management
The Nexera UC Unified Chromatography System from Shimadzu Scientific Instruments was recognized with an R&D100 award.
Shimadzu Scientific Intstruments has announced that its Nexera UC Unified Chromatography system had received an R&D magazine 100 Award, from R&D magazine identifying the system as one of the most technically significant new products of the year in the analytical and testing category.
The Nexera UC system combines supercritical fluidic extraction with supercritical fluid chromatography, eliminates the need for sample pre-treatment, and reduces the possibility of human error during analysis, the company reported in a Nov. 23, 2015 announcement.
According to the magazine, the Nexera UC takes five minutes to analyze pesticides in food and has a high target analyte recovery rate.
In selecting the Nexera UC for the award, R&D magazine reported that the system’s automated technology opens up new analytical opportunities in many fields, including drug discovery and delivery, chemicals, pharmaceuticals, and cleaning validation.
Source: Shimadzu Scientific Instruments
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
